A rigorous new study finds that a single dose of LSD can ease anxiety and depression for months. The study involved 198 adults with generalized anxiety disorder, or GAD, a disabling form of anxiety ...
On his podcast, Joe Rogan has repeatedly misinterpreted a graph showing changes in Earth's climate over the last 485 million years © Chris Unger/Zuffa LLC via Getty ...
Regeneron has reported a phase 3 win in generalized myasthenia gravis (gMG), positioning the pharma to file for FDA approval of its siRNA candidate in the increasingly competitive neuromuscular ...
Maxwell is serving time for sex trafficking related to the late Jeffrey Epstein. A federal judge in New York has denied the Trump administration's motion to unseal grand jury testimony from the ...
A year after debuting the “Rare Connections” series with a short film about patients’ experiences with neuromyelitis optica spectrum disorder (NMOSD), AstraZeneca’s rare disease unit is turning the ...
Findings showed gefurulimab statistically significantly improved MG-ADL total score at week 26 compared with placebo. Topline data were announced from a phase 3 trial evaluating gefurulimab in adults ...
Myasthenia gravis is a lifelong (chronic) autoimmune condition, which means that the body’s immune system attacks its own healthy cells. Most people with generalized myasthenia gravis (gMG) have ...
July 2 (Reuters) - Nvidia (NVDA.O), opens new tab reclaimed the top spot among the most valued companies worldwide in June, as its shares were supported by renewed optimism over its leadership in ...
Before Duolingo wiped its videos from TikTok and Instagram in mid-May, social media engagement was one of the language-learning app’s most recognizable qualities. Its green owl mascot had gone viral ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--H2O.ai, the #1 Agentic AI company, announced its h2oGPTe Agent has once again achieved the top ranking on the prestigious General AI Assistant (GAIA) benchmark, ...
Newsweek has created a graph to show how births in the United States have declined over the last 50 years. This has happened for every age group, fluctuating across the decades, rising steadily in the ...
Nipocalimab (Imaavy; Johnson & Johnson), an FcRn-blocking monoclonal antibody, was approved for patients 12 years and older with generalized myasthenia gravis based on data from the ongoing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results